On August 26, 2019 Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, reported that the Company’s management will present a Company overview and update, as well as host investor meetings, at the following September conferences (Press release, Supernus, AUG 26, 2019, View Source [SID1234538997]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo 2019 Healthcare Conference
Date: Thursday, September 5, 2019
Time: 1:20 p.m. ET
Place: The Westin Copley Place, Boston, MA

Morgan Stanley 2019 Global Healthcare Conference
Date: Wednesday, September 11, 2019
Time: 11:05 a.m. ET
Place: Grand Hyatt New York in New York City
Investors interested in arranging a meeting with the Company’s management during these conferences should contact the respective conference coordinator.

A live webcast of the presentations can be accessed by visiting ‘Events & Presentations’ in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay of these webcasts will be available for 60 days on the Company’s website after the conference.

On August 26, 2019 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body’s immune system to fight cancer, reported its participation at two upcoming investor conferences in New York City (Press release, Anixa Biosciences, AUG 26, 2019, View Source [SID1234538981]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will provide an overview of the company’s business during live presentations and will be available to participate in one-on-one meetings with investors who are registered to attend the conferences.

Details of Anixa’s presentations are as follows:

Event:

Rodman & Renshaw’s 21st Annual Global Investment Conference

Date:

Monday, September 9, 2019

Time:

2:35 p.m. EDT

Location:

Holmes I (4th Floor)

Lotte New York Palace Hotel, New York, NY

Event:

Janney Healthcare Conference

Date:

Tuesday, September 10, 2019

Time:

11:50 a.m. EDT

Location:

Bates Room

The Union League Club, New York, NY

The Rodman & Renshaw conference presentation will be webcast live and remain available for 90 days following the presentation. To access the webcast, please visit the investors section of Anixa’s website at View Source

On August 26, 2019 Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, reported Marty Duvall, chief executive officer, will present and webcast at the Baird 2019 Global Healthcare Conference in New York on Wednesday, September 4 at 2:30 PM Eastern (Press release, Tocagen, AUG 26, 2019, View Source [SID1234538980]). In addition, Tocagen will participate in Citi’s 14th Annual Biotech Conference in Boston on September 5.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live audio webcast from the Baird Conference and subsequent replay may be accessed by visiting Tocagen’s website. The webcast will be available shortly after conclusion of the presentation and archived on the company’s website for 30 days following the presentation.

On August 26, 2019 The Leukemia & Lymphoma Society – Southern Florida Chapter has reported Snap Crack Chiropractic as the Platinum Sponsor for the Miami Man & Woman of the Year Campaign for 2019 (Press release, The Leukemia & Lymphoma Society, AUG 26, 2019, View Source;woman-of-the-year-campaign-after-donating-100-000-to-the-leukemia–lymphoma-society-300906650.html [SID1234538979]). Snap Crack Chiropractic donated a total of $100,000 to the Leukemia & Lymphoma Society, which is dedicated to conducting research studies to advance lifesaving treatments for blood cancers.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Snap Crack Chiropractic is an easy, hassle-free chiropractic service that is designed to cater to healthy, yet fast-paced lifestyles by providing chiropractic services at an affordable price of $29. The goal of Snap Crack Chiropractic is to improve vitality, energy, and function while alleviating back pain and spinal misalignments.

The Leukemia & Lymphoma Society is the largest nonprofit organization with a mission to conduct research to find cures for blood cancers, including leukemia, lymphoma, Hodgkin’s disease, and myeloma. Since 1949, The Leukemia & Lymphoma Society has invested over $1 billion in revolutionary research to find cures for cancer in the blood. The mission of LLS is also rooted in improving the quality of life of blood cancer patients and their families.

On August 26, 2019 NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, reported that management will participate in the following investor events in September (Press release, NuVasive, AUG 26, 2019, View Source [SID1234538978]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Wells Fargo Securities 2019 Healthcare Conference at The Westin Copley Place in Boston on Wednesday, September 4, 2019 at 1:50 p.m. ET / 10:50 a.m. PT; and
Morgan Stanley 17th Annual Global Healthcare Conference at The Grand Hyatt New York in New York City on Tuesday, September 10, 2019 at 2:05 p.m. ET / 11:05 a.m. PT.
A live webcast of the presentations will be available online from the Investor Relations page of the Company’s website at www.nuvasive.com. A replay of the presentations will remain available on the website for 30 days after the live webcast.